Blue Trust’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$167 Sell
3
-191
-98% -$10.3K ﹤0.01% 2392
2026
Q2
$10.7K Sell
194
-116
-37% -$4.75K ﹤0.01% 1851
2026
Q1
$10.3K Hold
310
– – ﹤0.01% 1835
2025
Q4
$9.24K Sell
310
-1,197
-79% -$39.1K ﹤0.01% 1883
2025
Q3
$54.4K Hold
1,507
– – ﹤0.01% 1370
2025
Q2
$54.2K Sell
1,507
-616
-29% -$22.9K ﹤0.01% 1434
2025
Q1
$83.7K Buy
2,123
+236
+13% +$7.94K ﹤0.01% 1076
2024
Q4
$56.8K Buy
1,887
+371
+24% +$10.6K ﹤0.01% 1240
2024
Q3
$27K Buy
1,516
+849
+127% +$18.5K ﹤0.01% 1830
2024
Q2
$10.1K Buy
+667
New +$10.6K ﹤0.01% 1922
2023
Q3
– Sell
-33
Closed – – 2284
2023
Q2
$0 Sell
33
-28
-46% -$723 ﹤0.01% 2519
2023
Q1
$0 Sell
61
-35
-36% -$532 ﹤0.01% 2629
2022
Q4
$1K Sell
96
-12
-11% -$87 ﹤0.01% 2143
2022
Q3
$0 Buy
+108
New +$708 ﹤0.01% 2324

Other funds holding TGTX

Blue Trust's TGTX Position: Q3 2026 in Review

Blue Trust reduced its TG Therapeutics (TGTX) stake by 98% in Q3 2026, selling an estimated $10.3K and leaving 3 shares worth $167. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Blue Trust first reported a position in TGTX in Q3 2022 and has held it in 14 quarters since. The position peaked at $83.7K in Q1 2025. 370 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Blue Trust held 3 shares of TG Therapeutics worth $167 as of Q3 2026.
  • Blue Trust sold 191 TG Therapeutics shares in Q3 2026, an estimated $10.3K.
  • TG Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2392 holding.
  • Blue Trust first reported a position in TG Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Blue Trust's TG Therapeutics position peaked at $83.7K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.